Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-Year results of the randomized boost versus no boost EORTC 22881-10882 trial

Journal of Clinical Oncology

Volumn 25, Issue 22, 2007, Pages 3259-3265

  Bartelink, Harry ^a   Horiot, Jean Claude ^b   Poortmans, Philip M ^b   Struikmans, Henk ^b   Van Den Bogaert, Walter ^b   Fourquet, Alain ^b   Jager, Jos J ^b   Hoogenraad, Willem J ^b   Oei, S Bing ^b   Warlam Rodenhuis, Carla C ^b   Pierart, Marianne ^b   Collette, Laurence ^b  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST FIBROSIS; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; GROUPS BY AGE; HAZARD RATIO; HEALTH CARE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MORBIDITY; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE;

ADULT; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY DOSAGE; RISK FACTORS; TREATMENT OUTCOME;

EID: 34548243731     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.11.4991     Document Type: Article

References (32)

1. Fisher B, Anderson S, Bryant J, et al: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233-1241, 2002
2. Veronesi U, Cascinelli N, Mariani L, et al: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227-1232, 2002
3. Van Dongen JA, Bartelink H, Fentiman IS, et al: Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial 992. J Natl Cancer Inst Monogr 11:15-18, 1992
4. Blichert-Toft M, Rose C, Andersen JA, et al: Danish randomized trial comparing breast conservation therapy with mastectomy: Six years of life-table analysis - Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr 11:19-25, 1992
5. Jacobson JA, Danforth DN, Cowan KH, et al: Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 332:907-911, 1995
6. Sarrazin D, Le MG, Arriagada R, et al: Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol 14:177-184, 1989
7. Fisher B, Wickerham DL, Deutsch M: Breast tumour recurrence following lumpectomy with and without breast irradiation: An overview of recent NSABP findings. Semin Surg Oncol 8:153-160, 1992
8. Early Breast Cancer Trialists Collaborative Group (EBCTCG): Effects of radiotherapy and differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomized trial. Lancet 366:2087-2106, 2005
9. Curran D, Van Dongen JP, Aaronson NK, et al: Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: Results of EORTC Trial 10801. Eur J Cancer 34:307-314, 1998
10. van Dongen JA, Bartelink van Dongen JA, et al: Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 92:1143-1150, 2000
11. Romestaing P, Lehingue Y, Carrie C, et al: Role of a 10-Gy boost in the conservative treatment of early breast cancer: Results of a randomized clinical trial in Lyon, France. J Clin Oncol 15:963-968, 1997
12. Bartelink H, Horiot JC, Poortmans P, et al: Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 345:1378-1387, 2001
13. Poortmans P, Collette L, Horiot J-C, et al: Impact of the boost dose on local control and survival in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10 years results of the randomised EORTC boost trial 22881/10882. Radiother Oncol 81:S19, 2006 (abstr 54)
14. Pocock SJ, Simon R: Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 31:103-115, 1975
15. International Union Against Cancer: TNM Classification of Malignant Tumours (ed 4). New York: Springer-Verlag, 1987, pp 95-96
16. International Commission of Radiation Units and Measurements: Dose specification for reporting external beam therapy with photons and electrons: Report 50. Bethesda, MD, ICRU, 1992
17. Bartelink H, Garavaglia G, Johansson KA, et al: Quality assurance in conservative treatment of early breast cancer: Report on a Consensus Meeting of the EORTC Radiotherapy and Breast Cancer Cooperative Groups and the EUSOMA (European Society of Mastology). Radiother Oncol 22:323-326, 1991
18. van Tienhoven G, Van Bree NAM, Mijnheer BJ, et al: Quality assurance of the EORTC trial 22881/10882: "Assessment of the role of the booster dose in breast conserving therapy": the Dummy Run. Radiother Oncol 22:290-298, 1991
19. Hamers HP, Johansson KA, Venselaar JLM, et al: Entrance and exit TL-dosimetry in the conservative treatment of breast cancer: A pilot study for the EORTC Radiotherapy Cooperative Group. Radiother Oncol 22:280-284, 1991
20. Heukelom S, Lanson JH, Van Tienhoven G, et al: In vivo dosimetry during tangential breast treatment. Radiother Oncol 22:269-279, 1991
21. Poortmans PM, Ataman F, Davis JB, et al: Quality assurance in the EORTC phase III randomised 'boost vs. no boost' trial for breast conserving therapy: Comparison of the results of two individual case reviews performed early and late during the accrual period. Radiother Oncol 76:278-284, 2005
22. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
23. Gray RJ: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141-1154, 1988
24. Vrieling C, Collette L, Fourquet A, et al: Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? Eur J Cancer 39:932-944, 2003
25. de la Rochefordiere A, Asselain B, Campana F, et al: Age as prognostic factor in premenopausal breast carcinoma. Lancet 341:1039-1043, 1993
26. Albain KS, Allred DC, Clark GM: Breast cancer outcome and predictors of outcome: Are there age differentials? Monogr Natl Cancer Inst 16:35-42, 1994
27. Borger J, Kemperman H, Hart A, et al: Risk factors in breast-conservation therapy. J Clin Oncol 12:653-660, 1994
28. Voogd AC, Nielsen M, Peterse JL, et al: Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: Pooled results of two large European randomized trials. J Clin Oncol 19:1688-1697, 2001
29. Elkhuizen PHM, Van Slooten HJ, Clahsen PC, et al: High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy. J Clin Oncol 18:1075-1083, 2000
30. Zhou P, Recht A: Young age and outcome for women with early-stage invasive breast carcinoma. Cancer 101:1264-1274, 2004
31. Livi L, Paiar F, Saieva C, et al: Survival and breast relapse in 3834 patients with T1-T2 breast cancer after conserving surgery and adjuvant treatment. Radiother Oncol 82:287-293, 2007
32. Vrieling C, Collette L, Fourquet A, et al: The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "Boost versus No Boost" trial. Int J Radiat Oncol Biol Phys 45:677-685, 1999